Oramed Pharmaceuticals (ORMP) Stock Forecast for 2025, 2026, 2027. Sell or Buy Prediction







Where to Rent Stable Turkish Datacenter Proxies?

July 1, 2025 Where to Rent Stable Turkish Datacenter Proxies?

In a digital landscape where online anonymity and efficiency are essential, datacenter proxies have become a fundamental tool for businesses, SEO specialists, and…
PayPal’s News Analysis—A Short and Medium-Term Price Forecast

June 24, 2025 PayPal’s News Analysis—A Short and Medium-Term Price Forecast

This analytical article cuts through the noise, offering a focused forecast for PYPL’s stock price movement in both the short (5 days) and…
Understanding Accounting and Bookkeeping Services for Business Success

June 10, 2025 Understanding Accounting and Bookkeeping Services for Business Success

Every successful business relies on accurate financial records. From managing cash flow to ensuring compliance with tax regulations, reliable accounting and bookkeeping services…
How much does a Turkish passport cost?

May 27, 2025 How much does a Turkish passport cost?

Turkish citizenship comes with numerous benefits. Once granted, a foreigner can enter 126 countries visa-free, enjoy high-quality healthcare and favorable tax regimes, and…
How Measurement and Mix Modeling Drive Better Business Decisions

May 22, 2025 How Measurement and Mix Modeling Drive Better Business Decisions

In today’s data-driven business landscape, the ability to accurately measure and optimize marketing efforts has become a critical competitive advantage. As marketing evolves,…

Oramed Pharmaceuticals (ORMP) Stock Forecast for 2025, 2026, 2027. Sell or Buy?

Updated: July 7, 2025 (23:24)

Sector: Healthcare

The share price of Oramed Pharmaceuticals Inc. (ORMP) now

Latest session on the 7th of July for
Oramed Pharmaceuticals Inc. is negative
Trading Volume: 42655
Open: 2.17 /  High: 2.22 /  Low: 2.14
Current value: $2.17
What analysts predict: $3.25
52-week High/Low: $3.09 / $1.82
50-Day Moving Average: $2.223 — resistance level today
200-Day Moving Average: $2.325 — resistance level today

Are you interested in Oramed Pharmaceuticals Inc. stocks and want to buy them, or are they already in your portfolio? If yes, then on this page you will find useful information about the dynamics of the Oramed Pharmaceuticals stock price in 2025, 2026, 2027. How much will one Oramed Pharmaceuticals share be worth in 2025 - 2027?

When should I take profit in Oramed Pharmaceuticals stock? When should I record a loss on Oramed Pharmaceuticals stock? What are analysts' forecasts for Oramed Pharmaceuticals stock? What is the future of Oramed Pharmaceuticals stock? We forecast Oramed Pharmaceuticals stock performance using neural networks based on historical data on Oramed Pharmaceuticals stocks. Also, when forecasting, technical analysis tools are used, world geopolitical and news factors are taken into account.

Oramed Pharmaceuticals stock prediction results are shown below and presented in the form of graphs, tables and text information, divided into time intervals. (Next month, 2025, 2026, 2027, and ) The final quotes of the instrument at the close of the previous trading day are a signal to adjust the forecasts for Oramed Pharmaceuticals shares. This happens once a day.


Historical and forecast chart of Oramed Pharmaceuticals stock

The chart below shows the historical price of Oramed Pharmaceuticals stock and a prediction chart for the next month. For convenience, prices are divided by color. Forecast prices include: Optimistic Forecast, Pessimistic Forecast, and Weighted Average Best Forecast. Detailed values for the Oramed Pharmaceuticals stock price can be found in the table below.

Long-term forecasts by years.

Oramed Pharmaceuticals, Inc. engages in the provision of oral delivery solutions for drugs delivered via injection. It focuses in the research and development of pharmaceutical solutions, including an oral insulin capsule to be used for the treatment of individuals with diabetes, and the use of orally ingestible capsules or pills for delivery of other polypeptides. The company was founded by Nadav Kidron and Miriam Kidron on April 12, 2002 and is headquartered in New York, NY.

Trending Themes in the Healthcare Sector

Oramed Pharmaceuticals daily forecast for a month

Date Target Pes. Opt. Vol., %
Jul 09 2.17 2.14 2.20 2.98
Jul 10 2.18 2.16 2.20 1.78
Jul 11 2.18 2.16 2.20 1.90
Jul 12 2.18 2.16 2.20 1.66
Jul 13 2.21 2.20 2.25 2.23
Jul 14 2.20 2.18 2.21 1.82
Jul 15 2.20 2.19 2.22 1.59
Jul 16 2.22 2.19 2.24 2.25
Jul 17 2.22 2.19 2.23 2.03
Jul 18 2.21 2.19 2.23 2.16
Jul 19 2.17 2.15 2.19 1.76
Jul 20 2.17 2.15 2.18 1.41
Jul 21 2.16 2.15 2.19 1.97
Jul 22 2.19 2.16 2.20 1.68
Jul 23 2.18 2.17 2.20 1.67
Jul 24 2.21 2.18 2.22 1.76
Jul 25 2.20 2.18 2.21 1.43
Jul 26 2.20 2.18 2.23 2.31
Jul 27 2.22 2.20 2.23 1.37
Jul 28 2.23 2.20 2.27 3.07
Jul 29 2.24 2.23 2.27 1.89
Jul 30 2.24 2.22 2.27 2.59
Jul 31 2.23 2.21 2.26 2.20
Aug 01 2.22 2.20 2.23 1.41
Aug 02 2.26 2.24 2.29 2.22
Aug 03 2.28 2.25 2.31 2.86
Aug 04 2.29 2.26 2.32 2.56
Aug 05 2.28 2.25 2.31 2.42
Aug 06 2.26 2.25 2.29 1.99
Aug 07 2.24 2.22 2.28 2.88

Oramed Pharmaceuticals Daily Price Targets


Oramed Pharmaceuticals Stock Forecast 07-09-2025.

Forecast target price for 07-09-2025: $2.17.
Positive dynamics for Oramed Pharmaceuticals shares will prevail with possible volatility of 2.898%.
Pessimistic target level: 2.14
Optimistic target level: 2.20

Oramed Pharmaceuticals Stock Forecast 07-10-2025.

Forecast target price for 07-10-2025: $2.18.
Positive dynamics for Oramed Pharmaceuticals shares will prevail with possible volatility of 1.745%.
Pessimistic target level: 2.16
Optimistic target level: 2.20

Oramed Pharmaceuticals Stock Forecast 07-11-2025.

Forecast target price for 07-11-2025: $2.18.
Negative dynamics for Oramed Pharmaceuticals shares will prevail with possible volatility of 1.864%.
Pessimistic target level: 2.16
Optimistic target level: 2.20

Oramed Pharmaceuticals Stock Forecast 07-12-2025.

Forecast target price for 07-12-2025: $2.18.
Negative dynamics for Oramed Pharmaceuticals shares will prevail with possible volatility of 1.628%.
Pessimistic target level: 2.16
Optimistic target level: 2.20

Oramed Pharmaceuticals Stock Forecast 07-13-2025.

Forecast target price for 07-13-2025: $2.21.
Positive dynamics for Oramed Pharmaceuticals shares will prevail with possible volatility of 2.185%.
Pessimistic target level: 2.20
Optimistic target level: 2.25

Oramed Pharmaceuticals Stock Forecast 07-14-2025.

Forecast target price for 07-14-2025: $2.20.
Negative dynamics for Oramed Pharmaceuticals shares will prevail with possible volatility of 1.787%.
Pessimistic target level: 2.18
Optimistic target level: 2.21

ORMP (ORMP) Monthly Stock Prediction for 2025

Month Target Pes. Opt. Vol., %
Jul. 2.18 2.00 2.26 11.51
Aug. 2.40 2.28 2.51 9.11
Sep. 2.41 2.28 2.65 14.12
Oct. 2.31 2.21 2.41 8.42
Nov. 2.40 2.25 2.52 10.66
Dec. 2.54 2.43 2.74 11.05

Oramed Pharmaceuticals forecast for this year


Oramed Pharmaceuticals Stock Prediction for Jul 2025

An uptrend is forecast for this month with an optimal target price of $2.18275. Pessimistic: $2.00. Optimistic: $2.26


Oramed Pharmaceuticals Stock Prediction for Aug 2025

An uptrend is forecast for this month with an optimal target price of $2.39972. Pessimistic: $2.28. Optimistic: $2.51


Oramed Pharmaceuticals Stock Prediction for Sep 2025

An uptrend is forecast for this month with an optimal target price of $2.4098. Pessimistic: $2.28. Optimistic: $2.65


Oramed Pharmaceuticals Stock Prediction for Oct 2025

An downtrend is forecast for this month with an optimal target price of $2.30521. Pessimistic: $2.21. Optimistic: $2.41


Oramed Pharmaceuticals Stock Prediction for Nov 2025

An uptrend is forecast for this month with an optimal target price of $2.39558. Pessimistic: $2.25. Optimistic: $2.52


Oramed Pharmaceuticals Stock Prediction for Dec 2025

An uptrend is forecast for this month with an optimal target price of $2.53979. Pessimistic: $2.43. Optimistic: $2.74



Oramed Pharmaceuticals (ORMP) Monthly Stock Prediction for 2026

Month Target Pes. Opt. Vol., %
Jan 2.68 2.58 2.77 6.77
Feb 2.86 2.66 2.96 10.15
Mar 2.89 2.62 3.12 16.04
Apr 2.58 2.41 2.78 13.29
May 2.58 2.35 2.84 17.38
Jun 2.72 2.48 2.82 11.89
Jul 2.74 2.46 3.04 19.14
Aug 2.57 2.34 2.69 13.00
Sep 2.83 2.66 2.91 8.43
Oct 2.81 2.53 3.11 18.85
Nov 3.09 2.80 3.24 13.36
Dec 3.51 3.24 3.77 14.09

Oramed Pharmaceuticals (ORMP) Monthly Stock Prediction for 2027

Month Target Pes. Opt. Vol., %
Jan 3.74 3.40 4.13 17.72
Feb 3.57 3.42 3.84 11.06
Mar 3.51 3.15 3.88 18.78
Apr 3.58 3.44 3.86 10.78
May 3.83 3.50 4.26 17.88
Jun 3.67 3.32 4.05 17.89
Jul 4.18 4.04 4.43 8.85
Aug 4.43 4.14 4.71 12.00
Sep 4.95 4.77 5.50 13.25
Oct 5.16 4.74 5.60 15.24
Nov 5.21 4.67 5.36 12.92
Dec 5.01 4.78 5.24 8.83

Oramed Pharmaceuticals information and performance

Oramed Pharmaceuticals Address

HI-TECH PARK 2/4 GIVAT-RAM, PO BOX 39098, JERUSALEM, IL

Market Capitalization: 95 590 000 $

Market capitalization of the Oramed Pharmaceuticals Inc. is the total market value of all issued shares of a company. It is calculated by the formula multiplying the number of ORMP shares in the company outstanding by the market price of one share.

EBITDA: -14 152 000 $

EBITDA of Oramed Pharmaceuticals is earnings before interest, income tax and depreciation of assets.

PE Ratio: None

P/E ratio (price to earnings) - shows the ratio between the price of a share and the company's profit

PEG Ratio: N/A

Price/earnings to growth

DPS: None

Dividend Per Share is a financial indicator equal to the ratio of the company's net profit available for distribution to the annual average of ordinary shares.

DY: None

Dividend yield is a ratio that shows how much a company pays in dividends each year at the stock price.

EPS: -0.71

EPS shows how much of the net profit is accounted for by the common share.

Quarterly Earnings Growth YOY: N/A
Quarterly Revenue Growth YOY: -1
Trailing PE: -

Trailing P/E depends on what has already been done. It uses the current share price and divides it by the total earnings per share for the last 12 months.

Forward PE: -

Forward P/E uses projections of future earnings instead of final numbers.

EV To Revenue: 2.865

Enterprise Value (EV) /Revenue

EV To EBITDA: 0.524

The EV / EBITDA ratio shows the ratio of the cost (EV) to its profit before tax, interest and amortization (EBITDA).

Shares Outstanding: 40850500

Number of issued ordinary shares

Shares Float: N/A

Number of freely tradable shares

Shares Short Prior Month: N/A

Shares Short Prior Month - the number of shares in short positions in the last month.

Short Ratio: N/A
Percent Insiders: N/A
Percent Institutions: N/A

FAQ (Frequently Asked Questions about Oramed Pharmaceuticals Stock)

Should I Buy Oramed Pharmaceuticals Shares in 2025 year?

The maximum forecasted share price for next year is $3.51, which is $1.34 higher than the current stock price. By investing in Oramed Pharmaceuticals shares today for a one-year period, you could achieve a profit of 61.96%. With an investment horizon of up to two years, the target share price is $5.21. resulting in a profit of 139.89% ($3.04 per share).

Does Oramed Pharmaceuticals pay dividends?

No, it does not

Which economic sector do Oramed Pharmaceuticals's shares belong to?

Oramed Pharmaceuticals's shares belong to the "Healthcare" sector of economic.

Which other securities belong to the same sector as Oramed Pharmaceuticals's shares?

You can view all the stocks that are part of the same sector as Oramed Pharmaceuticals's shares in the Healthcare section.


Related stocks from Healthcare sector


Disclaimer:

All forecast data on the site are provided for informational purposes of using neural forecasting tools in the financial market and are not a call to action and, moreover, are not trading signals. When using the forecast data, the investor assumes all financial risks. The pandaforecast.com portal is not responsible for the loss of your money in the stock market as a result of using the information contained on the site.